Back to Search
Start Over
Roche to present data for fenebrutinib from Phase II FENopta OLE study
- Source :
- The Fly. September 4, 2024
- Publication Year :
- 2024
-
Abstract
- Roche will present new 48-week data for the investigational Bruton's tyrosine kinase, BTK, inhibitor fenebrutinib from the Phase II FENopta open-label extension, OLE, study at the 40th Congress of the [...]
- Subjects :
- Multiple sclerosis -- Research
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.807209422